A computational method to classify variants of uncertain significance using functional assay data with application to...

Area of Science:

• Genetics
• Bioinformatics
• Computational Biology

Background:

• Genetic testing for cancer predisposition can identify variants of uncertain clinical significance (VUS).
• Accurate classification of VUSs is critical for patient management, especially in hereditary breast and ovarian cancer syndrome.
• Non-informative genetic test results pose challenges for clinical decision-making.

Purpose of the Study:

• To develop and validate a computational approach for inferring the disease relevance of VUSs.
• To improve the classification of VUSs in cancer predisposition genes using in vitro functional assay data.
• To aid in clinical decision-making for individuals carrying VUSs.

Main Methods:

• A Bayesian hierarchical model was developed to analyze in vitro functional assay data.
• The model accounts for sources of experimental heterogeneity.
• The approach was applied to classify VUSs in the BRCT region of the BRCA1 gene.

Main Results:

• Functional data strongly correlate with the pathogenicity of BRCA1 BRCT VUSs.
• The computational model demonstrated high sensitivity and specificity in classifying VUSs.
• The approach provides valuable evidence for pathogenicity in the absence of family or genetic data.

Conclusions:

• The developed computational model effectively classifies VUSs in cancer predisposition genes.
• This approach aids in the clinical decision-making process for VUS carriers.
• Integration with other data types will be necessary for full clinical application.